1 / 12

The future of clinical trial funding

30/30 Horizons in Healthcare Research NHMRC CTC 30th Anniversary S ymposium 1 March 2019. The future of clinical trial funding. Professor Anne Kelso AO Chief Executive Officer. Clinical trials funding in NHMRC’s new grant program. NHMRC’s new grant program – four streams.

leal
Download Presentation

The future of clinical trial funding

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 30/30 Horizons in Healthcare ResearchNHMRC CTC 30th Anniversary Symposium 1 March 2019 The future of clinical trial funding Professor Anne Kelso AO Chief Executive Officer

  2. Clinical trials funding in NHMRC’s new grant program

  3. NHMRC’s new grant program – four streams * Researchers may hold one Investigator Grant or up to two Ideas Grants

  4. NHMRC’s new grant program – redividing the pie Old grant program New grant program Clinical Trials & Cohort Studies ~$70 million p.a.

  5. STRATEGIC AND LEVERAGING GRANTS To support research that addresses identified national needs • Includes new scheme – Clinical Trials and Cohort Studies • Objective: support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health • Open to research proposals for clinical trials and/or cohort studies of any size, including: • applications for new clinical trials and/or cohort studies • proposals to answer research questions using findings from existing trials or cohort studies. • Criteria: • Significance (40%) • Research Quality (40%) • Team Quality and Capability (20%)

  6. STRATEGIC AND LEVERAGING GRANTS To support research that addresses identified national needs • Includes new scheme – Clinical Trials and Cohort Studies • Objective: support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health • Open to research proposals for clinical trials and/or cohort studies of any size, including: • applications for new clinical trials and/or cohort studies • proposals to answer research questions using findings from existing trials or cohort studies. • Criteria: • Significance (40%) • Research Quality (40%) • Team Quality and Capability (20%)

  7. Timing of opening/closing of funding schemes in 2019

  8. Medical Research Future Fund

  9. NHMRC and MRFF budgets – to be updated 2 April 2019 Source: 2018-19 Portfolio Budget Statements

  10. The future of clinical trial funding - practicalities Watch GrantConnect! Read the Guidelines! • NHMRC will continue to support investigator-initiated clinical trials across all disease areas. • Scheme guidelines and peer review processes will need to keep up with new approaches to clinical trial design. • Scheme budgets will be reviewed annually as usual. • Scheme may evolve over time – please give us feedback. • MRFF is focussed on government priorities, which may change over time. • NHMRC will continue to deliver funding schemes (including clinical trial schemes) for MRFF at the request of Department of Health. • There are opportunities for future streamlining of NHMRC and MRFF clinical trial schemes.

  11. The future of clinical trial funding – in 30 years? • Funders will expect: • value: clear evidence of need, potential impact and pathway to uptake • end-user engagement: participant, policy maker, healthcare provider • international linkages for recruitment and data sharing • trial registration and open data sharing • trials embedded in routine clinical practice • Funders will need to provide: • data inter-operability (with ethics applications, registries etc) • flexibility to evaluate and fund new, more efficient trial designs • more frequent/continuous funding cycles • simple reporting mechanisms

  12. Thank you

More Related